CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 879 enrolled
Drug / intervention
complete blood count, PT, aPTT, fibrinogen testsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05929326
NCT05929326N/ACompleted

Establishment of Reference Intervals of Complete Blood Count and Coagulation Tests in Pregnant Women at Hung Vuong Hospital

Hung Vuong Hospital·observational·Posted Jul 3, 2023·Updated Jun 4, 2025

In Brief

An observational study evaluating complete blood count, PT, aPTT, fibrinogen tests for Pregnancy Related. Completed, enrolled 879 participants across 1 site.

Detailed Summary

Rationale: Pregnancy has major effects on physiology in women. There have been many studies that established reference intervals but none was done in Vietnam. The recommendation by CLSI C28-A3 is that if possible, each laboratory establishes its own reference intervals. Objective: To establish the reference intervals of complete blood count parameters and Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen. Study design: This is a cross-sectional study. Study population: Pregnant women with no history of disease and normal clinical findings.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesVietnam

Timeline

N/ACompletedFinished
202420252026
First PostedJul 3, 2023
Enrollment StartJun 9, 2023
Primary CompletionAug 21, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.0 years ago

Interventions

complete blood count, PT, aPTT, fibrinogen testsother

Pregnant women who are eligible for the study will have their blood collected to run complete blood count, PT, aPTT, fibrinogen tests